Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Regression of ocular neovascularization by periocular PEDF gene therapy

May 4, 2004

CpG ODN 1826 activates uveitogenic T-cells in mice

May 4, 2004

Promising topical ciclosporin prodrug against corneal graft rejection

May 3, 2004

PKC-412 improves retinal volume and visual acuity in DME patients

May 3, 2004

Vaccines suggested as an alternative for treating glaucoma

April 30, 2004

Adjunctive therapy with lerdelimumab after phacotrabeculectomy beneficial for IOP

April 30, 2004

Curcumin effective against human retinal endothelial cell proliferation

April 30, 2004

IND clearance for squalamine in neovascular diseases of the eye

April 26, 2004

Phase II trial of INS-37217 Ophthalmic for rhegmatogenous retinal detachment

April 26, 2004

Gatiflo eye drops receive Japanese approval

April 23, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...